Synonyms: CK-107 | CK-2127107 | CK2127107
Compound class:
Synthetic organic
Comment: Reldesemtiv (CK-2127107) is a second generation fast skeletal muscle troponin activator [1], that was designed to improve upon tirasemtiv. Reldesemtiv slows the rate of calcium release from the troponin complex, and sensitises the sarcomere to calcium which leads to increased contractility in fast skeletal muscle fibres. Like tirasemtiv, reldesemtiv was proposed to offer a therapeutic option for debilitating muscle weakness/muscle fatigue in diseases such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
1-[2-[[3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methylamino]pyrimidin-5-yl]pyrrole-3-carboxamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
10860 | reldesemtiv |
Synonyms ![]() |
CK-107 | CK-2127107 | CK2127107 |
Database Links ![]() |
|
ChEMBL Ligand | CHEMBL4297600 |
DrugBank Ligand | DB15256 |
GtoPdb PubChem SID | 458923836 |
PubChem CID | 67454400 |
Search Google for chemical match using the InChIKey | MQXWPWOCXGARRK-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | MQXWPWOCXGARRK |
Search PubMed clinical trials | reldesemtiv |
Search PubMed titles | reldesemtiv |
Search PubMed titles/abstracts | reldesemtiv |
UniChem Compound Search for chemical match using the InChIKey | MQXWPWOCXGARRK-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MQXWPWOCXGARRK-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖